Back to results
US 8,278,356 B2Granted
Phloroglucinol derivatives having selectin ligand activity
AssigneeRevotar Biopharmaceuticals AG
InventorsEwald Aydt, Remo Kranich
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or selectin binding.
Claims11
A compound of the formula (I):
- wherein the symbols and substituents have the following meaning:
- —X—Y is
- with m=0 or 1;
- n=an integer from 1 to 3;
- —Y is
- in which s is 0 or 1;
- R2 is CO2H, CO2alkyl, CO2aryl, CO2NH2, CO2aralkyl, CH2SO3H, CH2SO2NH2, CH2PO2(OH)2, SO3H, SO2NH2, PO(OH)2, 1-H-tetrazolyl-, CHO, COCH3, CH2OH, CH2NH2, NH2, CH2NHalkyl, CH2N(alkyl)alkyl′, NHalkyl, N(alkyl)alkyl′, OCH3, CH2OCH3, CH2SH, SH, F, Cl, Br, I, CH3, CH2CH3, CN, or CF3;
- R3 independently from R2 is H, CH3, CH2CH3, CF3, F, Cl, Br, I, CN, or NO2;
- R4 independently from R2 and R3 is H, CH3, CH2CH3, CF3, F, Cl, Br, I, CN, NO2, or R2;
- R5 is H, NO2, CF3, F, Cl, Br, I, CN, CH3, OCH3, SH, or NH2;
- —W— is —(CH2—)v, cis-CH═CH— or trans-CH═CH—, and v is 0, 1, or 2;
- in case that —W— is cis-CH═CH— or trans-CH═CH—, R2 must not be NH2 or SH;
- R6 independently from R2 is H, F, Cl, Me, tert-Bu, CN, or NH2;
- in which t is 0, 1, or 2;
- —Z is
- R7 independently from R2 is H, NO2, CF3, F, Cl, Br, I, CN, CH3, OCH3, SH, or NH2;
- in which K is NH, NMe, O, or S;
- or a pharmaceutically acceptable salt, ester, or amide thereof or a prodrug thereof of the above identified compounds of formula (I).
15 more elements
Dependencies are inferred from the claim text.